Triplications of human chromosome 21 orthologous regions in mice result in expansion of megakaryocyte-erythroid progenitors and reduction of granulocyte-macrophage progenitors

Chunhong Liu, Tao Yu, Zhuo Xing, Xiaoling Jiang, Yichen Li, Annie Pao, Justin Mu, Paul K. Wallace, George Stoica, Andrei V. Bakin, Y. Eugene Yu

Research output: Contribution to journalArticle

Abstract

Individuals with Down syndrome (DS) frequently have hematopoietic abnormalities, including transient myeloproliferative disorder and acute megakaryoblastic leukemia which are often accompanied by acquired GATA1 mutations that produce a truncated protein, GATA1s. The mouse has been used for modeling DS based on the syntenic conservation between human chromosome 21 (Hsa21) and three regions in the mouse genome located on mouse chromosome 10 (Mmu10), Mmu16 and Mmu17. To assess the impact of the dosage increase of Hsa21 gene orthologs on the hematopoietic system, we characterized the related phenotype in the Dp(10)1Yey/+;Dp(16)1Yey/+;Dp(17)1Yey/+ model which carries duplications spanning the entire Hsa21 orthologous regions on Mmu10, Mmu16 and Mmu17, and the Dp(10)1Yey/+;Dp(16)1Yey/+;Dp(17)1Yey/+;Gata1Yeym2 model which carries a Gata1s mutation we engineered. Both models exhibited anemia, macrocytosis, and myeloproliferative disorder. Similar to human DS, the megakaryocyte-erythrocyte progenitors (MEPs) and granulocyte-monocyte progenitors (GMPs) were significantly increased and reduced, respectively, in both models. The subsequent identification of all the aforementioned phenotypes in the Dp(16)1Yey/+ model suggests that the causative dosage sensitive gene(s) are in the Hsa21 orthologous region on Mmu16. Therefore, we reveal here for the first time that the human trisomy 21-associated major segmental chromosomal alterations in mice can lead to expanded MEP and reduced GMP populations, mimicking the dynamics of these myeloid progenitors in DS. These models will provide the critical systems for unraveling the molecular and cellular mechanism of DS-associated myeloproliferative disorder, and particularly for determining how human trisomy 21 leads to expansion of MEPs as well as how such an alteration leads to myeloproliferative disorder.

Original languageEnglish (US)
Pages (from-to)4773-4786
Number of pages14
JournalOncotarget
Volume9
Issue number4
DOIs
StatePublished - Jan 1 2018
Externally publishedYes

Fingerprint

Megakaryocyte-Erythroid Progenitor Cells
Chromosomes, Human, Pair 21
Granulocyte-Macrophage Progenitor Cells
Human Chromosomes
Down Syndrome
Myeloproliferative Disorders
Granulocyte Precursor Cells
Monocytes
Leukemia, Megakaryoblastic, Acute
Synteny
Phenotype
Hematopoietic System
Chromosomes, Human, Pair 10
Mutation
Gene Dosage
Population Dynamics
Anemia
Genome

Keywords

  • Down syndrome
  • Genetically engineered mouse models
  • Granulocyte-monocyte progenitors
  • Megakaryocyte-erythrocyte progenitors
  • Myeloproliferative disorder

ASJC Scopus subject areas

  • Oncology

Cite this

Triplications of human chromosome 21 orthologous regions in mice result in expansion of megakaryocyte-erythroid progenitors and reduction of granulocyte-macrophage progenitors. / Liu, Chunhong; Yu, Tao; Xing, Zhuo; Jiang, Xiaoling; Li, Yichen; Pao, Annie; Mu, Justin; Wallace, Paul K.; Stoica, George; Bakin, Andrei V.; Yu, Y. Eugene.

In: Oncotarget, Vol. 9, No. 4, 01.01.2018, p. 4773-4786.

Research output: Contribution to journalArticle

Liu, Chunhong ; Yu, Tao ; Xing, Zhuo ; Jiang, Xiaoling ; Li, Yichen ; Pao, Annie ; Mu, Justin ; Wallace, Paul K. ; Stoica, George ; Bakin, Andrei V. ; Yu, Y. Eugene. / Triplications of human chromosome 21 orthologous regions in mice result in expansion of megakaryocyte-erythroid progenitors and reduction of granulocyte-macrophage progenitors. In: Oncotarget. 2018 ; Vol. 9, No. 4. pp. 4773-4786.
@article{76bcec1d4ce64015941f141580846a8f,
title = "Triplications of human chromosome 21 orthologous regions in mice result in expansion of megakaryocyte-erythroid progenitors and reduction of granulocyte-macrophage progenitors",
abstract = "Individuals with Down syndrome (DS) frequently have hematopoietic abnormalities, including transient myeloproliferative disorder and acute megakaryoblastic leukemia which are often accompanied by acquired GATA1 mutations that produce a truncated protein, GATA1s. The mouse has been used for modeling DS based on the syntenic conservation between human chromosome 21 (Hsa21) and three regions in the mouse genome located on mouse chromosome 10 (Mmu10), Mmu16 and Mmu17. To assess the impact of the dosage increase of Hsa21 gene orthologs on the hematopoietic system, we characterized the related phenotype in the Dp(10)1Yey/+;Dp(16)1Yey/+;Dp(17)1Yey/+ model which carries duplications spanning the entire Hsa21 orthologous regions on Mmu10, Mmu16 and Mmu17, and the Dp(10)1Yey/+;Dp(16)1Yey/+;Dp(17)1Yey/+;Gata1Yeym2 model which carries a Gata1s mutation we engineered. Both models exhibited anemia, macrocytosis, and myeloproliferative disorder. Similar to human DS, the megakaryocyte-erythrocyte progenitors (MEPs) and granulocyte-monocyte progenitors (GMPs) were significantly increased and reduced, respectively, in both models. The subsequent identification of all the aforementioned phenotypes in the Dp(16)1Yey/+ model suggests that the causative dosage sensitive gene(s) are in the Hsa21 orthologous region on Mmu16. Therefore, we reveal here for the first time that the human trisomy 21-associated major segmental chromosomal alterations in mice can lead to expanded MEP and reduced GMP populations, mimicking the dynamics of these myeloid progenitors in DS. These models will provide the critical systems for unraveling the molecular and cellular mechanism of DS-associated myeloproliferative disorder, and particularly for determining how human trisomy 21 leads to expansion of MEPs as well as how such an alteration leads to myeloproliferative disorder.",
keywords = "Down syndrome, Genetically engineered mouse models, Granulocyte-monocyte progenitors, Megakaryocyte-erythrocyte progenitors, Myeloproliferative disorder",
author = "Chunhong Liu and Tao Yu and Zhuo Xing and Xiaoling Jiang and Yichen Li and Annie Pao and Justin Mu and Wallace, {Paul K.} and George Stoica and Bakin, {Andrei V.} and Yu, {Y. Eugene}",
year = "2018",
month = "1",
day = "1",
doi = "10.18632/oncotarget.23463",
language = "English (US)",
volume = "9",
pages = "4773--4786",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "4",

}

TY - JOUR

T1 - Triplications of human chromosome 21 orthologous regions in mice result in expansion of megakaryocyte-erythroid progenitors and reduction of granulocyte-macrophage progenitors

AU - Liu, Chunhong

AU - Yu, Tao

AU - Xing, Zhuo

AU - Jiang, Xiaoling

AU - Li, Yichen

AU - Pao, Annie

AU - Mu, Justin

AU - Wallace, Paul K.

AU - Stoica, George

AU - Bakin, Andrei V.

AU - Yu, Y. Eugene

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Individuals with Down syndrome (DS) frequently have hematopoietic abnormalities, including transient myeloproliferative disorder and acute megakaryoblastic leukemia which are often accompanied by acquired GATA1 mutations that produce a truncated protein, GATA1s. The mouse has been used for modeling DS based on the syntenic conservation between human chromosome 21 (Hsa21) and three regions in the mouse genome located on mouse chromosome 10 (Mmu10), Mmu16 and Mmu17. To assess the impact of the dosage increase of Hsa21 gene orthologs on the hematopoietic system, we characterized the related phenotype in the Dp(10)1Yey/+;Dp(16)1Yey/+;Dp(17)1Yey/+ model which carries duplications spanning the entire Hsa21 orthologous regions on Mmu10, Mmu16 and Mmu17, and the Dp(10)1Yey/+;Dp(16)1Yey/+;Dp(17)1Yey/+;Gata1Yeym2 model which carries a Gata1s mutation we engineered. Both models exhibited anemia, macrocytosis, and myeloproliferative disorder. Similar to human DS, the megakaryocyte-erythrocyte progenitors (MEPs) and granulocyte-monocyte progenitors (GMPs) were significantly increased and reduced, respectively, in both models. The subsequent identification of all the aforementioned phenotypes in the Dp(16)1Yey/+ model suggests that the causative dosage sensitive gene(s) are in the Hsa21 orthologous region on Mmu16. Therefore, we reveal here for the first time that the human trisomy 21-associated major segmental chromosomal alterations in mice can lead to expanded MEP and reduced GMP populations, mimicking the dynamics of these myeloid progenitors in DS. These models will provide the critical systems for unraveling the molecular and cellular mechanism of DS-associated myeloproliferative disorder, and particularly for determining how human trisomy 21 leads to expansion of MEPs as well as how such an alteration leads to myeloproliferative disorder.

AB - Individuals with Down syndrome (DS) frequently have hematopoietic abnormalities, including transient myeloproliferative disorder and acute megakaryoblastic leukemia which are often accompanied by acquired GATA1 mutations that produce a truncated protein, GATA1s. The mouse has been used for modeling DS based on the syntenic conservation between human chromosome 21 (Hsa21) and three regions in the mouse genome located on mouse chromosome 10 (Mmu10), Mmu16 and Mmu17. To assess the impact of the dosage increase of Hsa21 gene orthologs on the hematopoietic system, we characterized the related phenotype in the Dp(10)1Yey/+;Dp(16)1Yey/+;Dp(17)1Yey/+ model which carries duplications spanning the entire Hsa21 orthologous regions on Mmu10, Mmu16 and Mmu17, and the Dp(10)1Yey/+;Dp(16)1Yey/+;Dp(17)1Yey/+;Gata1Yeym2 model which carries a Gata1s mutation we engineered. Both models exhibited anemia, macrocytosis, and myeloproliferative disorder. Similar to human DS, the megakaryocyte-erythrocyte progenitors (MEPs) and granulocyte-monocyte progenitors (GMPs) were significantly increased and reduced, respectively, in both models. The subsequent identification of all the aforementioned phenotypes in the Dp(16)1Yey/+ model suggests that the causative dosage sensitive gene(s) are in the Hsa21 orthologous region on Mmu16. Therefore, we reveal here for the first time that the human trisomy 21-associated major segmental chromosomal alterations in mice can lead to expanded MEP and reduced GMP populations, mimicking the dynamics of these myeloid progenitors in DS. These models will provide the critical systems for unraveling the molecular and cellular mechanism of DS-associated myeloproliferative disorder, and particularly for determining how human trisomy 21 leads to expansion of MEPs as well as how such an alteration leads to myeloproliferative disorder.

KW - Down syndrome

KW - Genetically engineered mouse models

KW - Granulocyte-monocyte progenitors

KW - Megakaryocyte-erythrocyte progenitors

KW - Myeloproliferative disorder

UR - http://www.scopus.com/inward/record.url?scp=85040444948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040444948&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.23463

DO - 10.18632/oncotarget.23463

M3 - Article

C2 - 29435140

AN - SCOPUS:85040444948

VL - 9

SP - 4773

EP - 4786

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 4

ER -